三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LABU 三倍做多标普生物-Direxion

未开盘 07-08 16:00:00 EDT

317.19

-5.43

-1.68%

盘后314.20

-2.99-0.94%

19:57 EDT

最高323.70	最低296.37	成交量62.85万
今开313.35	昨收322.62	日振幅8.47%
总市值7.37亿	流通市值7.37亿	总股本232.45万
成交额1.95亿	换手率27.04%	流通股本232.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":317.19,"timestamp":1783540800000,"preClose":322.62,"halted":0,"volume":628496,"hourTrading":{"tag":"盘后","latestPrice":314.2,"preClose":317.19,"latestTime":"19:57 EDT","volume":4910,"amount":1545175.9648,"timestamp":1783555031680,"change":-2.99,"changeRate":-0.009427,"amplitude":0.010971},"delay":0,"changeRate":-0.01683094662451183,"floatShares":2324486,"shares":2324486,"eps":0,"marketStatus":"未开盘","change":-5.43,"latestTime":"07-08 16:00:00 EDT","open":313.35,"high":323.7,"low":296.37,"amount":194548485.6656,"amplitude":0.084713,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783584000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":322.62,"sharesOutstanding":3024486,"nav":322.545,"aum":765878555.87,"dividendRate":0.003153,"bidAskSpread":0.002681,"preHourTrading":{"tag":"盘前","latestPrice":313.03,"preClose":322.62,"latestTime":"09:29 EDT","volume":12292,"amount":3820844.0508,"timestamp":1783517399999,"change":-9.59,"changeRate":-0.029725,"amplitude":0.051728},"postHourTrading":{"tag":"盘后","latestPrice":314.2,"preClose":317.19,"latestTime":"19:57 EDT","volume":4910,"amount":1545175.9648,"timestamp":1783555031680,"change":-2.99,"changeRate":-0.009427,"amplitude":0.010971},"volumeRatio":1.345686,"impliedVol":1.0126,"impliedVolPercentile":0.8924},"requestUrl":"/m/hq/s/LABU","defaultTab":"news","newsList":[{"id":"2649874996","title":"强生(JNJ)适配房颤等手术的双能量消融导管获美FDA批准上市 将于今夏分阶段商业化投放","url":"https://stock-news.laohu8.com/highlight/detail?id=2649874996","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649874996?lang=zh_cn&edition=full","pubTime":"2026-07-08 20:44","pubTimestamp":1783514687,"startTime":"0","endTime":"0","summary":"强生医疗电生理与神经血管业务负责人 Michael Bodner 表示，该产品此前已在欧洲完成商业化落地，此次 FDA 获批将快速扩大美国市场可及性，是公司电生理管线重要创新里程碑。产品将于 2026 年夏季启动美国分阶段商业化投放，陆续开展临床手术。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/NjkwOTdhNzcyN2U0YmYwYmQ0MTU5ZmNlZDZlMGU5OTExMDg1MTQ4NjI3MDM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjkwOTdhNzcyN2U0YmYwYmQ0MTU5ZmNlZDZlMGU5OTExMDg1MTQ4NjI3MDM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302342","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.USD","LU0466842654.USD","LU0943347566.SGD","LU1121112475.USD","BMED","IE00BKVL7J92.USD","LU1430594728.SGD","LU1066053197.SGD","IPOS","LU2236285917.USD","IE00B19Z3581.USD","FHLC","BK4504","PJP","LU1066051498.USD","XLV","BK4532","LU0820562030.AUD","JDOC","IE000BZT7R73.USD","LU0787776722.HKD","LU2133065610.SGD","LU0964807845.USD","RXL","LU2403377893.USD","LU2089984988.USD","VHT","IXJ","LU0345769631.USD","LU1267930813.SGD","FTXH","IHE","LU0912757837.SGD","IE00B42XCP33.USD","LU2129689514.USD","LU2430703251.USD","LABU","IE000WAW04H5.SGD","IE0000B7K699.USD","MEDX","IYH","LU1061106388.HKD","JNJ","LU1894683348.USD","BK4568","LU2505996681.GBP","LU2471134523.USD","LU1935042991.SGD","GDOC","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649533967","title":"花旗集团将GE医疗保健公司目标股价从65美元上调至69美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649533967","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649533967?lang=zh_cn&edition=full","pubTime":"2026-07-08 18:09","pubTimestamp":1783505341,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UDN","LU1366192091.USD","XBI","LU1791807156.HKD","IYF","LU1551013342.USD","LU0203345920.USD","LU1201861249.SGD","LU1551013425.SGD","UXI","DFEN","LU0052756011.USD","LU1119994496.HKD","LU0820561818.USD","LU0354030438.USD","LU2168564222.USD","LU1093756168.USD","LU2168564149.EUR","LU0648001328.SGD","FTXO","LU2456880835.USD","LU2264538146.SGD","LU2125154778.USD","NOBL","XLV","XAR","EXI","LU0820562030.AUD","LU2125154935.USD","LU0267386448.USD","UUP","LU0130102774.USD","VHT","LU0203347892.USD","GE","ITA","NATO","BK4585","LU0072461881.USD","LU2168563687.JPY","PPA","LU0162691827.USD","LABU","LU0354030511.USD","LU1064131342.USD","LU2168564065.EUR","LU0477156953.USD","MISL","LU1244550494.USD","LU0314106906.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139526358","title":"医疗保健板块热点速递：市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1139526358","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139526358?lang=zh_cn&edition=full","pubTime":"2026-07-08 16:25","pubTimestamp":1783499145,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场动态速递。摩根士丹利分析师德里克·杰利内克看好瑞思迈出售其MatrixCare部门，认为此举有助于这家呼吸技术提供商进一步聚焦核心战略。杰利内克向客户表示，此次资产剥离将成熟资产变现，所获资金用于回馈股东，应有助于支撑瑞思迈的股价。该股目前下跌0.3%，报31.345澳元。其在澳大利亚证交所上市的股票下跌0.5%，报31.29澳元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XLV","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649293243","title":"Monica Jeffs将出任Concorde Career Colleges休斯顿新校区校长","url":"https://stock-news.laohu8.com/highlight/detail?id=2649293243","media":"环球市场播报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649293243?lang=zh_cn&edition=full","pubTime":"2026-07-08 03:21","pubTimestamp":1783452060,"startTime":"0","endTime":"0","summary":"环球技术学院旗下医疗保健教育部门Concorde Career Colleges宣布，Monica Jeffs已被任命为其新建休斯顿校区的校长。　　Concorde Career Colleges总裁Kevin Prehn表示，Monica是一位充满活力的高等教育领导者，在推动机构发展、运营卓越和学生成功方面拥有良好的业绩记录。　　Concorde Career Colleges是Universal Technical Institute， Inc．的医疗保健教育部门，致力于培养护理、牙科、呼吸、诊断及相关健康领域的专业人才。目前，Concorde在八个州运营着18个校区，并提供在线教育项目。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-08/doc-inifzmys5032885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4550","BK4585","BK4581","BK4588","NOBL","VHT","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111378876","title":"Vera Therapeutics股价飙升：肾病新药获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111378876","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111378876?lang=zh_cn&edition=full","pubTime":"2026-07-08 02:47","pubTimestamp":1783450047,"startTime":"0","endTime":"0","summary":"周二，Vera Therapeutics, Inc.的股价上涨约8%，此前美国食品药品监督管理局批准了其用于治疗IgA肾病的药物。这款名为Trutakna的药物通过阻断两种蛋白质来发挥作用，这两种蛋白质会促使免疫系统产生抗体，这些抗体在肾脏中积聚并造成损伤。这是美国首个获批同时靶向这两种蛋白质的药物，尽管已有其他几种药物治疗该疾病。福泰制药正在研发一种同样能阻断这两种蛋白质的类似药物，FDA预计将在今年晚些时候对此做出裁决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU2417539215.USD","LU0432979614.USD","LABU","LU2456880835.USD","SG9999001176.SGD","IE00B19Z9P08.USD","IE00B894F039.SGD","LU2362540622.SGD","IE0002270589.USD","LU2462157665.USD","BK4532","IE00BJT1NW94.SGD","LU1674673428.USD","IE00BFTCPJ56.SGD","IBBQ","LU0320765992.SGD","IE00BJJMRZ35.SGD","IDNA","IE00B2B36J28.USD","SG9999013999.USD","BK4539","LU1093756168.USD","LU2362541513.USD","IE00BZ9MQY76.HKD","LU0256863811.USD","LU2237438978.USD","BK4585","BBH","BK4139","LU1093756325.SGD","LU1430594728.SGD","LU0823416689.USD","BK4533","BIB","LU2324357040.USD","BK4588","IE00B4R5TH58.HKD","LU0079474960.USD","LU0058720904.USD","IE00B19Z9Z06.USD","IE0002141913.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU0289739699.SGD","SG9999001176.USD","LU1778281490.HKD","LU0061475181.USD","PBE","LU1069344957.HKD","LU1674673691.USD","LU1585245621.USD","LU2236285917.USD","SGXZ57979304.SGD","VRTX","LU0889565916.HKD","VERA","LU0109394709.USD","IE0009355771.USD","LU0234570918.USD","IBB","LU1035775433.USD","BK4567","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196918036","title":"医疗健康板块动态：市场热议","url":"https://stock-news.laohu8.com/highlight/detail?id=1196918036","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196918036?lang=zh_cn&edition=full","pubTime":"2026-07-08 00:21","pubTimestamp":1783441307,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康板块的市场热议。分析师们提到了Mounjaro在国际市场的持续放量，以及美国肥胖药物市场的健康增长。他们补充说，还预计将有一系列即将到来的催化剂，这些因素有望巩固礼来在价值超过2000亿美元的肠促胰岛素市场中的领导地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","LU0912757837.SGD","LU0267386448.USD","LU1732800096.USD","LU0795875086.SGD","BSL.SI","LU0106831901.USD","BK4516","LU1720051017.SGD","BK4581","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU1988902786.USD","LU2023251221.USD","BK6092","LU1064131342.USD","LU0882574139.USD","IAI","LABU","BK4588","IE00BKVL7J92.USD","LU0528227936.USD","LU0971096721.USD","LU1074936037.SGD","LU0098860793.USD","LU1363072403.SGD","LU1732799900.SGD","XLV","LU0106261372.USD","LU2264538146.SGD","LU2089283258.USD","LU0320765646.SGD","LU1244550577.SGD","MS","BK6511","LU2028103732.USD","LU1548497426.USD","LU1791710582.SGD","LU1720051108.HKD","LU0158827948.USD","XBI","LU2487616109.SGD","BK4585","LU0795875169.SGD","LU1162221912.USD","LU1791710400.SGD","LU2347655156.SGD","BK4127","LU0557290698.USD","LU2133065610.SGD","LU1244550221.USD","LU1989772923.USD","LU0210528500.USD","LU1668664300.SGD","LU0158827781.USD","BK4504","KBWB","LU2089284900.SGD","BK4534","LU0006306889.USD","LU0225283273.USD","LU0234570918.USD","LU2111349929.HKD","LU2357305700.SGD","LU1244550494.USD","LU0053666078.USD","LU0314104364.USD","LU2271345857.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2649898409","title":"ALTERITY THERAPEUTICS：美国FDA同意一项关键性3期临床试验加上确证性证据，即可支持ATH434用于","url":"https://stock-news.laohu8.com/highlight/detail?id=2649898409","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649898409?lang=zh_cn&edition=full","pubTime":"2026-07-07 18:06","pubTimestamp":1783418790,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","LABU","BK4585","IBBQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649362102","title":"Evercore任命Eric Rabinowitz为医疗健康投资银行部高级董事总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2649362102","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649362102?lang=zh_cn&edition=full","pubTime":"2026-07-06 20:50","pubTimestamp":1783342200,"startTime":"0","endTime":"0","summary":"独立投资银行Evercore今日宣布，Eric Rabinowitz已加入公司，担任医疗健康投资银行部高级董事总经理。　　Rabinowitz在医疗健康投行领域拥有超过二十年的从业经验。加入Evercore前，他在高盛担任医疗健康投行部董事总经理，主导了多项大型生物制药并购和许可交易，交易总价值超过1000亿美元。　　Evercore医疗健康投行部全球负责人表示，Rabinowitz的加入将显著增强团队在生物制药领域的服务能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-06/doc-inifwscu8547306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GABF","KCE","EVR","XLV","159760","LABU","IXJ","BK4550","PFI","BK4581","VHT","BK4585","XBI","BK4588","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649017621","title":"FDA批准Zyn“危害性更低”营销声明 尼古丁袋市场迎新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2649017621","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649017621?lang=zh_cn&edition=full","pubTime":"2026-07-06 20:45","pubTimestamp":1783341900,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局近日批准了菲利普·莫里斯公司旗下20款Zyn尼古丁袋产品的修改风险烟草产品申请，允许其向消费者宣称该产品比传统卷烟“危害性更低”。这一决定被视为尼古丁替代产品领域的重大突破。　　FDA在公告中表示，根据科学证据评估，Zyn尼古丁袋通过将尼古丁经口腔黏膜吸收，避免了燃烧产生的焦油和一氧化碳等有害物质，从而显著降低健康风险。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-06/doc-inifwscu8543452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","162414","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649614593","title":"歌礼制药-B(01672)向美国FDA递交两项治疗肥胖症的IND申请：多肽胰淀素受体激动剂月注射剂ASC36以及ASC36联合多肽GLP-1R/GIPR激动剂ASC35的ASC36_35复方月注射剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2649614593","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649614593?lang=zh_cn&edition=full","pubTime":"2026-07-06 08:08","pubTimestamp":1783296500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，近期已向美国食品药品监督管理局 递交了两项新药临床试验申请：每月一次至每季度一次新一代多肽胰淀素受体激动剂ASC36，以及ASC36_35 FDC，即ASC36联合多肽GLP-1R/GIPR 激动剂ASC35的每月一次注射复方制剂，用于治疗肥胖症。临床前研究已确立了ASC36注射剂及ASC36_35 FDC复方注射剂的优越疗效。在ASC35 SALD月制剂近期取得的里程碑基础上，我们已递交ASC36月注射剂及 ASC36_35复方月注射剂两项IND。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4144","IND","JDOC","BK1574","LABU","01477","BK4160","BK4588","BK4590","GLP","BK1161","01672","BK4585","BK1515","BK1191","GIPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648890691","title":"娃哈哈一茶饮检测出甜蜜素，遭美国FDA“进口警报”，官方暂无回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2648890691","media":"新浪科技","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648890691?lang=zh_cn&edition=full","pubTime":"2026-07-04 22:25","pubTimestamp":1783175100,"startTime":"0","endTime":"0","summary":"7月4日，据报道，美国FDA 近日披露的一份“进口警报”文件显示，娃哈哈集团2026年4月6日生产的一款“红茶及柠檬调味茶”饮料中检测出甜蜜素，并将其类型标注为“DWPE”。只要食品中含有甜蜜素，在FDA眼中就属于“含有不安全食品添加剂”。　　对于上述情况，新浪财经问询了娃哈哈方面，截至发稿前其尚未对该情况作出明确回复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-04/doc-inifscxw9311340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648998976","title":"张琅：健康中国政策的落地进一步释放商业健康保险空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2648998976","media":"金融一线","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648998976?lang=zh_cn&edition=full","pubTime":"2026-07-04 17:50","pubTimestamp":1783158600,"startTime":"0","endTime":"0","summary":"　　谈及未来行业发展机遇，张琅表示，健康中国政策的落地进一步释放商业健康保险空间。　　张琅进一步表示，对于健康险，无论是从健康中国还是投资于人，金融监管总局推动健康保险高质量发展、医保局创新药的放开，都是我们的机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/insurance/2026-07-04/doc-inifrtka9359402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","XBI","BK4588","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114431356","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1114431356","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114431356?lang=zh_cn&edition=full","pubTime":"2026-07-04 16:21","pubTimestamp":1783153298,"startTime":"0","endTime":"0","summary":"最新医疗保健板块市场动态。益普生股价下跌1.1%。联昌国际证券分析师表示，受4月和5月意外收益的推动，马来西亚手套制造商的股价预计在8月财报季期间将保持相对坚挺。然而，他预计下半年前景将更具挑战性，因为平均销售价格将随着原材料成本下降和持续的行业产能过剩而下滑。随着固定成本居高不下，利润率压力可能会加剧。联昌国际维持对马来西亚手套制造业的中性评级，并将高产柅品工业列为其首选。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4588","BK4581","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648695750","title":"云康云科医疗健康科技（广州）有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2648695750","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648695750?lang=zh_cn&edition=full","pubTime":"2026-07-04 11:33","pubTimestamp":1783135980,"startTime":"0","endTime":"0","summary":"天眼查App显示，近日，云康云科医疗健康科技（广州）有限公司成立，注册资本800万元，经营范围包括健康咨询服务、远程健康管理服务、医学研究和试验发展、人工智能通用应用系统等，由云康健康产业投资股份有限公司全资持股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607043794165922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159760","LABU","IXJ","XBI","XLV","VHT","BK4585","BK4550","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190197931","title":"医疗保健板块动态：市场热议聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1190197931","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190197931?lang=zh_cn&edition=full","pubTime":"2026-07-04 04:52","pubTimestamp":1783111925,"startTime":"0","endTime":"0","summary":"0848 ET - 益普生集团本周宣布了两项收购，但其首席商务官菲利普·洛佩斯-费尔南德斯在接受采访时表示，这更像是机缘巧合而非预先计划。这家法国制药商表示，将以高达17.5亿美元的价格收购致力于研发罕见血癌药物的Kartos Therapeutics公司，并在另一项可能超过7亿欧元的交易中，收购专注于肾脏感染治疗的Memo Therapeutics公司。联昌国际集团、国家能源公司、IHH医疗保健集团和金务大公司是其首选股票之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138259959","title":"医疗保健板块圆桌：市场热议焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=1138259959","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138259959?lang=zh_cn&edition=full","pubTime":"2026-07-04 00:25","pubTimestamp":1783095922,"startTime":"0","endTime":"0","summary":"医疗保健领域的最新市场对话正在热烈进行。0848 ET - 益普生集团本周宣布了两项收购，但该公司首席商务官菲利普·洛佩斯-费尔南德斯在访谈中表示，这更像是机缘巧合而非精心策划的结果。该股股价下跌1.1%。鉴于对成本压力升级可能削弱消费者和企业信心并导致资产质量恶化的担忧，他们对银行盈利采取了更为保守的立场。联昌国际集团、国家能源、综合保健控股和金务大是他们的首选标的之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","XBI","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648076654","title":"健友股份(603707.SH)子公司获得美国FDA醋酸去氨加压素注射液药品生产场地转移注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2648076654","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648076654?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:34","pubTimestamp":1783067659,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 健友股份(603707.SH)发布公告，公司子公司Meitheal Pharmaceuticals, Inc.(以下简称“Meitheal”)于近日收到美国食品药品监督管理局(以下简称“美国FDA”)签发的醋酸去氨加压素注射液，4mcg/mL 和40mcg/10mL(ANDA号：074888)生产场地转移批准信，批准在公司子公司健进制药有限公司场地生产。本次获批印证公司无菌注射剂生产线及质量体系满足美国cGMP标准，丰富公司北美医疗机构注射剂管线，完善海外自有供应链体系，中长期有望为公司经营业绩带来积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462874.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","LABU","BK0186","BK0239","BK0046","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654882","title":"健友股份：子公司获美国FDA醋酸去氨加压素注射液生产场地转移批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648654882?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:14","pubTimestamp":1783066453,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648507245","title":"美国劳工统计局：专业和商业服务、社会援助以及医疗保健领域的就业岗位持续增加。休闲和酒店业的就业岗位减少。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648507245","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648507245?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:32","pubTimestamp":1782995569,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XLV","BK4581","BK4585","LABU","VHT","BK4550","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648650958","title":"FDA扩大福泰(VRTX)Casgevy基因疗法适用人群 两岁及以上血液病患儿可纳入治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2648650958","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648650958?lang=zh_cn&edition=full","pubTime":"2026-07-02 18:03","pubTimestamp":1782986636,"startTime":"0","endTime":"0","summary":"Casgevy 依托 CRISPR 基因编辑技术改造患者自体造血干细胞，从根源改善血红蛋白缺陷问题，减少患者长期输血与血管闭塞危象发作频次，属于一次性治疗型细胞疗法。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302133","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU0417517546.SGD","LU2456880835.USD","LU0109394709.USD","LU2462157665.USD","BK4139","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1093756325.SGD","LU2362541513.USD","LU0256863811.USD","LU1778281490.HKD","LU2417539215.USD","IE0009355771.USD","LU2237438978.USD","LU1674673691.USD","IE00B19Z9Z06.USD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4585","LU2236285917.USD","LU1585245621.USD","IE00B2B36J28.USD","BK4532","LU0889565916.HKD","SGXZ57979304.SGD","LU2324357040.USD","VRTX","LU0234570918.USD","BK4533","LU0320765992.SGD","BK4588","LU0061475181.USD","LU2362540622.SGD","LABU","LU1093756168.USD","SG9999001176.USD","BK4567","IE0002141913.USD","LU0079474960.USD","SG9999001176.SGD","LU1069344957.HKD","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2362541273.HKD","IE00BJT1NW94.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1241},{"period":"1month","weight":0.993},{"period":"3month","weight":0.7407},{"period":"6month","weight":0.8911},{"period":"1year","weight":4.2576},{"period":"ytd","weight":0.99}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0084},{"period":"3month","weight":0.0963},{"period":"6month","weight":0.074},{"period":"1year","weight":0.2016},{"period":"ytd","weight":0.0931}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.020883},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.009536},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.135885},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.001739},{"month":5,"riseRate":0.545455,"avgChangeRate":0.013816},{"month":6,"riseRate":0.75,"avgChangeRate":0.158596},{"month":7,"riseRate":0.666667,"avgChangeRate":0.056921},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.004065},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.0652},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.047038},{"month":11,"riseRate":0.818182,"avgChangeRate":0.199161},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.032237}],"exchange":"ARCA","name":"三倍做多标普生物-Direxion","nameEN":"Direxion Daily S&P Biotech Bull 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三倍做多标普生物-Direxion,LABU,三倍做多标普生物-Direxion股票,三倍做多标普生物-Direxion股票老虎,三倍做多标普生物-Direxion股票老虎国际,三倍做多标普生物-Direxion行情,三倍做多标普生物-Direxion股票行情,三倍做多标普生物-Direxion股价,三倍做多标普生物-Direxion股市,三倍做多标普生物-Direxion股票价格,三倍做多标普生物-Direxion股票交易,三倍做多标普生物-Direxion股票购买,三倍做多标普生物-Direxion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}